Background {#Sec1}
==========

Cancer is the most common health issue in South Korea due to its aging population, in which the prevalence rate of chronic diseases has been increasing \[[@CR1]\]. To reduce problems related to cancer, many studies have been conducted and treatment strategies, such as endoscopic procedures, surgery, chemotherapy, and radiotherapy that considers a patient's condition according to each cancer stage, were developed \[[@CR2], [@CR3]\]. Hence, survival rates of cancer patients showed a rapid increase of about 25% over the recent decade, and cancer is increasingly being considered as a type of chronic disease that requires timely diagnosis and treatment rather than as an incurable disease \[[@CR4]\]. Nevertheless, cancer incidence has generally increased, and it remains as the most frequent cause of death (age-standardized mortality rate 90.2 per 100,000; 27.6% of all deaths in 2012) \[[@CR4]\]. Among all types of cancer, stomach cancer is the second most frequent and the third highest causes of death in South Korea (age-standardized incidence rate 39.9 per 100,000 in 2012; age-standardized mortality rate 11.2 per 100,000 in 2012) \[[@CR4]\]. Given the high frequency and mortality of stomach cancer compared to other cancers, it is necessary to devise effective alternatives for managing South Korean stomach cancer patients.

Stomach cancer is usually treated by surgical treatment rather than by chemotherapy or radiotherapy \[[@CR5]\]. Previous surgical studies proposed many theories and alternatives to achieve better surgical outcomes, and the volume-outcome relationship was described in most cases. This was because physicians or hospital personnel who treat more surgical cases can develop their skills, resulting in better outcomes, although an excessive volume could lead to negative outcomes \[[@CR6]\]. Given that the number of cancer patients in early stages of the disease has gradually increased due to new medical technologies and screening methods, the number of patients who undergo surgical treatment has also increased \[[@CR7]--[@CR9]\]. Therefore, many studies focusing on the volume-outcome relationship for cancer patients have been published \[[@CR10]--[@CR12]\]. However, most of the previous studies focused on better outcomes in higher volume groups, rather than suggesting a specific volume threshold that can guide clinical decision-making to improve outcomes. In addition, only a few studies are available regarding the volume-outcome relationship for cancer patients in South Korea and other Asian countries. Therefore, we investigated the relationship between surgical volume for stomach cancer patients and mortality as an extension of previous studies on the volume-outcome relationship in cancer patients, using nationally representative data in South Korea. Our findings suggest an optimal volume for achieving good outcomes for stomach cancer patients, and the results may assist in the clinical decision-making and establishment of effective health policies.

Methods {#Sec2}
=======

Database and data collection {#Sec3}
----------------------------

We used the National Health Insurance Service (NHIS) Sample Cohort data during 2002--2013 in this study. This data included a 1,025,340 population which was collected through a systematic sampling to extract a 2.2% nationally representative sample among 46,605,433 Koreans in 2002, and it included all healthcare claims that were filed during 2002 to 2013. To analyze the relationship of stomach cancer surgical volume for cancer-specific mortality, we only included patients with newly diagnosed stomach cancer (International Classification of Diseases (ICD)-10: C16) and undergoing gastrectomy as their first treatment since 2004. Finally, the data used in this study were from 2550 newly diagnosed stomach cancer patients who received surgical treatment from 2004 to 2013.

Variables {#Sec4}
---------

The dependent variable used in this study was mortality of patients with newly diagnosed stomach cancer (ICD-10: C16). It was defined as cancer-specific mortality in patients with stomach cancer. We selected the first date of each patient's hospital visit regardless of types of visits and followed the stomach cancer patient. Patient mortality in the study population was assumed to be the result of worsening status due to cancer.

The interesting variable in this study was surgical volume for stomach cancer patients at each hospital over a 1-year period. To identify the threshold for optimal surgical volume in a positive volume-outcome relationship, we analyzed the optimal cutoff value of surgical volumes to achieve an efficient volume-outcome relationship related to cancer-specific mortality, using the Youden index (sensitivity + specificity − 1) and the formula shown below. The Youden index is the maximum vertical distance between ROC and a diagonal line; it is the idea for maximizing the difference between true positive and false positive. The optimal cutoff refers to where the Youden index is at its highest value \[[@CR13]--[@CR15]\].$$\documentclass[12pt]{minimal}
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*P* = probability at maximizing the Youden index; *β* ~0~ = intercept; *β* ~1~ = coefficient of surgical volume.

Based on the cutoff volume, we categorized the surgical volume into two groups and then additionally calculated the cutoff values for each group. By estimation, we selected the following threshold values: low (\<3.0), mid-low (3.0--16.0), mid-high (16.0--30.0), and high (\>30.0).

We also adjusted other independent variables to analyze the association between the surgical volume in each hospital and the mortality of patients who underwent surgical treatment for stomach cancer. Other independent variables were sex, age, income level, types of insurance coverage, types of surgery, types of treatment, dissection of lymph node, Charlson Comorbidity Index (CCI), region, and types of medical institution. We divided the age groups by intervals of 10 years from 40 to 70 years to reflect the variety in patient outcomes according to aging, and below 30 years and above 70 years were merged, respectively. Types of insurance coverage in South Korean were defined into three groups as medical aid, National Health Insurance (NHI) employee insurance, or NHI self-employed insurance according to the National Health Insurance act. Beneficiaries of NHI employee insurance comprised of either workers or employers in workplaces and also included their family who live together. They pay about 7% of their average salary as premium, and the rates changed every year. Beneficiaries of NHI self-employed insurance were people for whom the criteria for the NHI employee did not apply. Their premium is accounted based on both their income which does not occur in the workplace and their property. Medical aid was applied to people with lower income compared to government-defined poverty level and people with a disability. They could be provided free medical care by government funds. By those criteria of NHI benefit, the type of insurance coverage could reflect the socioeconomic status of South Koreans. To reflect the severity of stomach cancer in patients, we included treatment variables. Types of surgery were classified into total and subtotal gastrectomy, as well as by whether lymph node dissection was included \[[@CR16], [@CR17]\]. Types of treatment were classified into surgery with chemotherapy and radiotherapy, surgery with chemotherapy, surgery with radiotherapy, and only surgery \[[@CR18]\]. The CCI was calculated by weighting and scoring for other comorbid conditions besides cancer \[[@CR19]\]. Hospital region was defined as hospitals that provided surgical treatment for patients with stomach cancer in capital regions (Seoul and Gyeonggi) and others \[[@CR20]\].

Statistical analysis {#Sec5}
--------------------

In this study, we analyzed the descriptive statistics such as frequency or percentages of the study population in a categorical variable at the baseline of study, and then we analyzed chi-square tests for categorical variables and cancer-specific mortality. In continuous variables, we showed the means and standard deviations as descriptive statistics and also analyzed *t* tests by cancer-specific mortality. For suggesting the differences of cancer-specific survival times by the surgical volume groups, we showed the Kaplan-Meier survival curves with log-rank tests. Finally, to suggest the association of surgical volume in each hospital for cancer-specific mortality, we analyzed survival analyses adopting the Cox proportional hazard model while adjusting other covariates. Sub-group analyses were also performed to investigate the differences in the association of surgical volume for cancer-specific mortality according to region and types of surgery or treatment. SAS statistical software version 9.4 (Cary, NC) was used in all analyses of this study.

Results {#Sec6}
=======

There were 2550 patients with newly diagnosed stomach cancer during 2004 to 2013. Overall, 17.10% of patients died due to cancer over the study period. Stomach cancer patients who received surgical treatment at hospitals with higher surgical volumes had lower mortality. Patients with vulnerable socioeconomic status, such as old age or low finances, experienced higher mortality. With regard to severity indicators, patients who received total gastrectomy or complex therapy had higher mortality. In addition, patients who died from cancer had higher CCI scores (Table [1](#Tab1){ref-type="table"}).Table 1General characteristics of patients with stomach cancer at baseline and distribution of those by cancer-specific mortalityVariablesTotalDiedSurvived*P* value*N*/mean%/SD*N*/mean%/SD*N*/mean%/SDSex Male173968.2031418.06142581.940.0598 Female81131.8012215.0468984.96Age (years) −391104.311412.739687.27\<0.0001 40--4937914.864812.6633187.34 50--5965025.498212.6256887.38 60--6976830.1213717.8463182.16 70+64325.2215524.1148875.89Income −4071628.0812717.7458982.260.6956 41--7067826.5911316.6756583.33 71--9069227.1412417.9256882.08 91+46418.207215.5239284.48Types of insurance coverage Medical aid873.412326.446473.560.0399 NHI, self-employed91535.8816217.7075382.30 NHI, employed154860.7125116.21129783.79Year of surgery 20042389.337029.4116870.59\<0.0001 20052449.575924.1818575.82 20062298.985021.8317978.17 20072168.476027.7815672.22 200826610.434617.2922082.71 20092529.884819.0520480.95 201026310.314416.7321983.27 201128811.29269.0326290.97 201228010.98279.6425390.36 201327410.7562.1926897.81Types of surgery Total gastrectomy55221.6517431.5237868.48\<0.0001 Subtotal gastrectomy199878.3526213.11173686.89Types of treatment With chemotherapy and radiotherapy441.732761.361738.64\<0.0001 With chemotherapy37314.6317847.7219552.28 With radiotherapy90.35777.78222.22 Only surgery212483.2922410.55190089.45Dissection of lymph node Yes253199.2543117.03207581.980.3081 No441.73511.363988.64CCI0.791.431.051.720.741.36\<0.0001Hospital characteristics Hospital volume  Low (*N* = 368)43617.105913.5337786.47\<0.0001  Mid-low (*N* = 292)35714.004011.2031788.80  Mid-high (*N* = 27)127349.9222717.83104682.17  High (*N* = 17)48418.9811022.7337477.27 Region of hospital  Capital area (*N* = 328)95137.2915015.7780184.230.1705  Others (*N* = 376)90535.4928631.601313145.08 Types of medical institution  General hospital (*N* = 689)253199.2543016.99210183.010.0924  Hospital (*N* = 15)190.75631.581368.42Total2550100.0043617.10211482.90

Kaplan-Meier survival curves with log-rank test for suggesting cancer-specific survival time by the surgical volume were shown in Fig. [1](#Fig1){ref-type="fig"}. The survival time from the first diagnosis of stomach cancer to cancer-specific death was shorter in patients who received surgical treatment at hospitals with lower surgical volumes (*P* for log-rank test \<0.0001).Fig. 1Kaplan-Meier survival curves and log-rank test results comparing survival rates between patients with stomach cancer by surgical volume

The results of survival analysis to analyze the association between surgical volume and cancer-specific mortality among patients with stomach cancer are shown in Table [2](#Tab2){ref-type="table"}. Although the risk of mortality among patients who received surgical treatment gradually decreased with increasing surgical volume, the mortality risk increased again in "high" surgical volume hospitals, producing a j-shaped curve (mid-low = hazard ratio (HR) 0.773, 95% confidence interval (CI) 0.608--0.983; mid-high = HR 0.541, 95% CI 0.372--0.788; high = HR 0.659, 95% CI 0.473--0.917; ref = low). In addition, the risk of morality from cancer was significantly different according to severity indicators. Patients who received total gastrectomy or complex therapy, including surgery, as treatment for stomach cancer had a higher risk of mortality, although stratifying by CCI was not statistically significant.Table 2Results of survival analysis using the Cox proportional hazard model to examine the association between surgical volume and cancer-specific mortalityVariablesMortality due to cancerHR95% CI*P* valuePatient characteristics Sex  Male1.1320.9141.4010.2571  Female1.000------ Age (years)  −391.000------  40--491.0360.5681.8920.9071  50--591.1360.6402.0160.6640  60--691.8051.0313.1620.0388  70+4.2522.4067.513\<.0001 Income  −401.0330.7551.4120.8410  41--701.1660.8591.5820.3249  71--901.0770.7971.4550.6303  91+1.000------ Types of insurance coverage  Medical Aid1.3930.8632.2470.1749  NHI, self-employed0.9910.8081.2170.9338  NHI, employed1.000------ Year of surgery  20041.000------  20050.8810.6181.2550.4818  20060.8540.5891.2400.4078  20071.0080.7071.4380.9640  20080.7650.5191.1270.1752  20091.0500.7141.5430.8043  20100.7870.5251.1790.2460  20110.6640.4151.0610.0868  20121.1730.7331.8790.5060  20130.9480.4032.2320.9032 Types of surgery  Total gastrectomy2.2281.8232.724\<.0001  Subtotal gastrectomy1.000------ Types of treatment  With chemotherapy and radiotherapy4.6053.0107.043\<.0001  With chemotherapy6.1394.9357.636\<.0001  With radiotherapy9.0684.07120.199\<.0001  Only surgery1.000------ Dissection of lymph node  Yes0.9830.4032.3980.9708  No1.000------ CCI1.0510.9951.1110.0739Hospital characteristics Hospital volume  Low1.000------  Mid-low0.7730.6080.9830.0356  Mid-high0.5410.3720.7880.0014  High0.6590.4730.9170.0135 Region of hospital  Capital area1.1310.9241.3850.2316  Others1.000------ Types of medical institution  General hospital0.3110.1330.7290.0072  Hospital1.000------

We also performed sub-group analyses to investigate differences in the relationship between surgical volume and cancer-specific mortality according to region and types of surgery or treatment. The risk of mortality gradually decreased with increasing surgical volume, although some j-shaped curve trends were observed. The reduction in mortality risk by higher surgical volume was greater in patients who received surgical treatment at hospitals located outside the capital, as well as in those who received subtotal gastrectomy or only surgery (Fig. [2](#Fig2){ref-type="fig"}).Fig. 2Results of sub-group analyses for the relationship between surgical volume and mortality due to cancer according to hospital regions, types of surgery, or types of treatment. The references level was low in surgical volume groups. \**P* \< 0.1; \*\**P* \< 0.05

Discussion {#Sec7}
==========

As cancer patients were continuously increased, healthcare professionals have put a significant amount of effort to achieve better surgical outcomes, including the analysis of volume-outcome relationship. According to previous studies, patients who received treatment at hospitals with high surgical volume had better outcomes. Although the authors of those studies suggested alternatives to improve patient outcomes, only a few identified threshold values for the volume-outcome relationship \[[@CR10], [@CR11]\]. Therefore, to improve surgical outcomes, we investigated the relationship between surgical volumes that were categorized by the Youden index and cancer-specific mortality among patients with stomach cancer.

The risk of mortality from cancer was lower in hospitals with higher surgical volumes, similar to previous studies on the volume-outcome relationship; however, such positive effects decreased after exceeding a certain level of surgical volume \[[@CR10], [@CR21]\]. Our findings may suggest a guideline for maximizing the surgical outcomes of stomach cancer patients. Hospitals with mid-high surgical volumes had the best outcomes. Considering the fact that data in this study were collected by a systematic sampling method (about 2.2% of the entire population), the optimal threshold of surgical volume was approximately 727.3 surgical cases for stomach cancer per hospital annually (16.0 \* 100/2.2 = 727.3). However, if surgical volume exceeded about 1363.6, the shown benefit disappeared.

The current study also revealed some interesting findings by sub-group analyses. For instance, reductions in mortality from cancer showed different trends according to region, type of surgery, and type of treatment. The volume-outcome relationship was only statistically significant in hospitals outside the capital region. We hypothesized that there were no specific differences in surgical skills between hospitals in the capital area, since all of the hospitals had substantial surgical volumes for cancer and, therefore, sufficient experience \[[@CR20], [@CR22]\]. Differences by the type of surgery or treatment may have resulted as better surgical skills have less impact on severe cases \[[@CR16], [@CR18]\]. Therefore, the positive effect of higher surgical volume was only observed for patients undergoing subtotal gastrectomy or only surgery. Based on our results, health policymakers and healthcare professionals may have to figure out alternatives or guidelines that can maximize patient outcomes.

Our study had some strengths. First, our data used a national sampling cohort to investigate the association between surgical volume for stomach cancer and cancer-specific mortality. Thus, the results of this study would be a positive role in making evidence-based cancer policies for optimal management of stomach patients who require surgical treatment. Second, to suggest an optimal threshold for surgical volume, we calculated the cutoff value for surgical volume using the Youden index. This enabled the selection of an optimal threshold for surgical volume with the best outcomes for stomach cancer surgery. Although a number of previous studies investigated surgical volume-outcome relationship in cancer, only a few suggested a threshold volume for efficient outcomes. Therefore, our findings may suggest helpful evidence-based criteria or methods for the cancer policies for optimal management of cancer patients.

Our study also had some limitations. Cancer staging is a major factor in cancer treatment, as it reflects severity of cancer patients. Health outcomes of cancer patients differ based on cancer staging, and a patient's hospital preference might also differ by their clinical severity. However, we could not identify any information on cancer staging, including the SEER summary staging, due to limitation of data \[[@CR23]\]. To minimize such limitation, we considered types of surgery, types of treatment during treatment period of each patient, and dissection of lymph node on surgery as covariates. Second, we only included patients who received surgical treatment for stomach cancer to avoid large differences in severity \[[@CR2]\], as healthcare claim data had no information on cancer staging such as SEER. Third, given that the average period from the first diagnosis of stomach cancer to death was about 4 years, there were several potential confounders related to disease management such as detailed severity indicators, socioeconomic factors, or food consumption. All of the listed factors have the potential to influence health outcomes in patients undergoing stomach cancer surgery, even with the inclusion of variables such as the Charlson Comorbidity Index, which reflects the clinical status of patients with gastric cancer \[[@CR24]\]. However, since our study used health insurance claim data, which were collected to provide payment for both patients and providers based on medical utilization, we could not account for such confounders. Fourth, detailed characteristics of hospital and human resources, such as surgeon volume or surgeon experience, could serve a positive role in cancer care, particularly for surgical outcomes. However, we could not consider such detailed characteristics due to data limitation, despite consideration of some hospital characteristics. Fifth, the Health Insurance Review and Assessment (HIRA) in South Korea initiated healthcare quality assessments for managing gastric cancer patients after 2014. While positive impacts on quality of care are expected, the current study was conducted before this program was applied. Finally, South Korea is known to offer one of the world's best gastric cancer care systems, due to its relatively high incidence and the corresponding burden of the disease. Therefore, surgical volumes of gastric cancer may not be generalized in other countries, and healthcare systems and implementation of the recommended thresholds may not be realistic. Nevertheless, suggestion of alternatives in finding the optimal surgical volume for maximizing surgical outcomes can be helpful in establishing an efficient healthcare policy or providing optimal case management for cancer care \[[@CR25]\]. Despite some limitations, our findings suggested that cancer mortality decreased in hospitals with higher surgical volumes, as similarly stated in previous studies on the volume-outcome relationship. However, such positive effects decreased for very high-volume hospitals. These associations were especially significant in regions with low surgical volumes and less severe cases. Although further studies using more detailed data are required, our results underscore the need for health policymakers and healthcare professionals to identify effective ways to improve cancer management and reduce stomach cancer mortality in South Korea.

Conclusion {#Sec8}
==========

Higher surgical volume for stomach cancer is associated with lower mortality. Our results suggest that the optimal threshold of surgical volume for good outcomes was about 727.3 surgical cases for stomach cancer per hospital annually in South Korea, but such positive effects decreased after exceeding a certain level of surgeries.
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